 VICTORIA, British Columbia-- BUSINESS WIRE --IPA IMMUNOPRECISE ANTIBODIES LTD. the Company or IPA NASDAQ: IPA, an advanced biotherapeutic research and technology company, today announced that it will host a conference call to discuss its quarterly results and recent business highlights for second quarter fiscal year 2023, on Thursday, December 15, 2022, at 10:30 am Eastern Time. The financial results will be issued in a press release prior to the call. 